medigraphic.com
ISSN 1405-1710 (Print)

2020, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2020; 29 (1)

Reticulated acropigmentation of Kitamura

Olguín-García MG, Palacios-Reyes MC, González-González M, Marmolejo-Chavira M

Language: Spanish
References: 18
Page: 10-15
PDF size: 361.94 Kb.


ABSTRACT

In this article, we report the case of a 29-year-old female with multiple punctate brown macules, arranged in a reticular pattern, on the dorsa of the hands and feet. Some of them are located over atrophic skin. She was also found to have pitting of the skin in both palms, following her dermatoglyphic pattern. Her clinical findings are consistent with the diagnosis of reticulate acropigmentation of Kitamura, an uncommon and benign autosomal dominant genodermatosis.


REFERENCES

  1. Kitamura K ASNS HIFU shikisoijo. RNHH. No Title. 1943; 8: 4.

  2. OMIM. Reticulate acropigmentation of Kitamura (RAK). p. #615537.

  3. Al Hawsawi K, Al Aboud K, Alfadley A, Al Aboud D. Reticulate, acropigmentation of Kitamura & Dowling Degos disease overlap: a case report. Int J Dermatol. 2002; 41: 518-520.

  4. Rathoriya S, Soni SL, Asati D. Dowling-Degos disease with reticulate acropigmentation of Kitamura: extended spectrum of a single entity. Indian Dermatol Online J. 2016; 7: 32-35.

  5. Müller CSL, Pföhler C, Tilgen W. Changing a concept-controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol. 2009; 36: 44-48.

  6. Kono M, Sugiura K, Suganuma M, Hayashi M, Takama H, Suzuki T et al. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease. Hum Mol Genet. 2013; 22: 3524-3533.

  7. Kono M, Suganuma M, Takama H, Suzuki T, Matsunaga K, Tomita Y et al. Dowling-Degos disease is genetically and clinico-pathologically distinct from reticulate acropigmentation of Kitamura, further confirmation. J Dermatol Sci. 2016; 84: e81.

  8. Prevalence and incidence of rare diseases: bibliographic data. 2017: 1-74. Orphadata databese, www.orphadata.org.

  9. Kawaguchi M, Hearing VJ. The roles of ADAMs family proteinases in skin diseases. Enzyme Res. 2011; 2011: 1-9.

  10. Kawaguchi M, Hozumi Y, Suzuki T. ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes. J Dermatol Sci. 2015; 78: 133-142.

  11. Okamura K, Abe Y, Araki Y, Hozumi Y, Kawaguchi M, Suzuki T. Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura. Pigment Cell Melanoma Res. 2016; 29: 243-246.

  12. Koguchi H, Ujiie H, Aoyagi S, Osawa R, Shimizu H. Characteristic findings of handprint and dermoscopy in reticulate acropigmentation of Kitamura. Clin Exp Dermatol. 2014; 39: 85-87.

  13. Calonje JE, Brenn T, Phillip MA. McKee’s pathology of the skin. 4th ed. China: Saunders; 2011. p. 1906.

  14. Kameyama K, Morita M, Sugaya K, Nishiyama S, Hearing VJ. Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study. J Am Acad Dermatol. 1992; 26: 817-820.

  15. Fahad AS, Shahwan HA, Dayel SB. Treatment of reticulated acropigmentation of Kitamura with Q-switched alexandrite laser. Int J Dermatol. 2011; 50: 1150-1152.

  16. Hyung Lee J, Hee Lee J, Heung Lee J. A case of reticulate acropigmentation of Kitamura treated with 532-nm Q-Switched Nd: YAG Laser: 10 years of follow-up observation. Ann Dermatol. 2014; 26: 783-785.

  17. Wu YH, Lin YC. Generalized Dowling-Degos disease. J Am Acad Dermatol. 2007; 57: 327-334.

  18. Mehta D, Raval N, Patadiya H, Tarsariya V. Gorlin-Goltz syndrome. Ann Med Health Sci Res. 2014; 4: 279-282.




2020     |     www.medigraphic.com